ASE Technology Holding Co., Ltd. Q3 FY2026 earnings call

• LEAP Dominance: Leading-edge advanced packaging (LEAP) capacities are running at or near full utilization, driving disproportionate growth in profitability. LEAP services are increasingly viewed as the manufacturing basis for future electronics generations beyond just AI.
• Margin Expansion: The traditional 'structural margin ceiling' no longer applies due to the rapid shift toward high-margin LEAP products. Management expects gross margins to remain dynamic, with quarterly improvements anticipated as LEAP mix increases.
• Full Process & CPO: Full process business is entering mass production with multiple customer engagements. Co-Packaged Optics (CPO) is expected to generate over half a billion USD in revenue next year, with mass production starting in Q4 2026.
• Capacity Constraints: Space/facility availability is the primary bottleneck for expansion. The company is aggressively pursuing facility acquisitions and has 22 ongoing building projects in Taiwan, more than half of which will support revenue through 2027.
• EMS Dynamics: While EMS revenue grew significantly, margins were pressured by rising raw material costs from AI-related component shortages. However, long-term synergy between ATM and EMS for system-level solutions remains a strategic priority.

The company reported record consolidated net revenues of $244.2 billion (NTD), representing a 28% sequential and 45% year-over-year increase. Gross profit was $54 billion with a gross margin of 22.1%. The ATM business generated $151.5 billion in revenue, accounting for 62% of total consolidated revenue and 91% of operating profits; its gross margin expanded to 30.6%, up 3.3 percentage points sequentially. The EMS business contributed $93.5 billion in revenue, or 38% of the total, with a gross margin of 8.3%, which declined 0.6 percentage points sequentially due to higher pass-through component costs.

• Q4 2026 Consolidated Revenue: Expected to grow 6% to 8% sequentially.
• Q4 2026 Margins: Consolidated gross margin projected at 23%-24%; operating margin at 14.5%-15.5%.
• ATM Business: Revenue expected to grow 11%-13% sequentially; gross margin expected to increase by 100-200 basis points.
• EMS Business: Revenue expected to be flat sequentially; operating margin expected around 2%.
• FY2026 LEAP Revenue: Upwardly revised to exceed $4 billion USD (previously $3.7 billion).
• FY2026 CapEx: Increased to $11.5 billion USD (up from $10.5 billion); further increases expected for FY2027.

• Capital Expenditure & Cash Flow: Aggressive CapEx spending leads to negative cash flow and increased debt levels, though management views this as necessary for growth.
• Facility Acquisition Challenges: Intense competition for suitable factory spaces in Taiwan creates execution risk in scaling new capacity quickly.
• Component Cost Volatility: Rising raw material costs in the EMS segment can compress margins if not fully offset by pricing.
• Supply Chain Constraints: Continued tightness in supply across both leading-edge and mainstream packaging/testing sectors requires prioritization of investment.

Q: Analysts asked about the sustainability of gross margins after exceeding historical structural ceilings and requested details on the highest-performing LEAP processes.

A: CFO Joseph Tung stated that the old structural margin ceiling is now the new base, expecting sequential quarterly margin improvements driven by LEAP ramp-up and favorable pricing. He declined to disclose specific margins for individual package types but confirmed overall LEAP assembly and test margins are accretive to growth.

Q: Questions focused on the financial outlook for the Full Process business and the specific revenue contribution from Co-Packaged Optics (CPO).

A: Management projected over $1 billion in revenue from Full Process next year, constrained primarily by space rather than demand. For CPO, they expect over $500 million in revenue next year, with mass production beginning in Q4 2026. NPO and CPO will coexist based on performance requirements.

Q: Analysts inquired about the capital expenditure trajectory for 2027 and funding sources given the aggressive expansion plans.

A: Management indicated that FY2027 CapEx will likely exceed the current year’s level due to strong demand visibility. They plan to utilize multiple cost-effective funding sources, including trade financing with customers, acknowledging continued negative free cash flow in the near term as they invest heavily in facilities and equipment.

Q: Concerns were raised regarding competitive dynamics, specifically if competitors like TSNC subsidiaries entering substrate business would erode ASE's market share or trigger price wars.

A: Management asserted their dominant position in the field, noting that competitor moves are largely out of necessity. They emphasized that the sheer scale difference prevents price wars and that ASE remains in a 'catch-up mode' to meet overwhelming demand rather than fighting for share.